The relationship between the cold chain system and vaccine potency in Taiwan: (II) Oral polio vaccine

Journal of Food and Drug Analysis

Volumn 8, Issue 1, 2000, Pages 17-23

  Wang, Der Yuan ^a   Yang, Ruoh Ing ^a   Yang, Yi Chen ^a   Yeh, Sheng Yen ^a   Chen, Tso Ling ^a   Cheng, Hwei Fang ^a   Hsieh, Juen Tian ^a   Lin, Chia Po ^a  

^a DEPARTMENT OF HEALTH   (Taiwan)

Author keywords

Cold chain system; Oral poliovirus vaccine; Potency test

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; DRUG EFFICACY; DRUG POTENCY; DRUG STORAGE; HUMAN; HUMAN CELL; INFECTION CONTROL; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; TAIWAN; TEMPERATURE DEPENDENCE;

EID: 0034034331     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Huang, L. M. and Lee, C. Y. 1996. Immunogenicity of Oral Polio Vaccine (I). The commissioned research report of Department of Health, Executive Yuan, R.O.C.
2. de Quadros, C. A., Hersh, B. S., Olive, J. M., Andrus, J. K., da Silveira, C. M. and Carrasco, P. A. 1997. Eradication of wild poliovirus from the Americas: Acute flaccids papalysis surveillance, 1988-1995. J. Infect. Dis. 175: S37-S42.
3. Dowdle, W. R. and Birmingham, M. E. 1997. The biologic principles of poliovirus eradication. J. Infect. Dis. 175: S286-S292.
4. Kim-Farley, R. J., Rutherford, G., Iichfield, P., Hsu, S. T., Orenstein, W. A., Schonberger, L. B., Bart, K. J. and Lin, C. C. 1984. Outbreak of paralytic poliomyelitis, Taiwan. Lancet 2: 1322-1324.
5. Huang, L. M. and Lee, C. Y. 1997. Immunogenicity of Oral Polio Vaccine (II). The research report of Department of Health, Executive Yuan, R.O.C.
6. Tydeman, M. S. and Kirkwood, T. B. L. 1984. Design and analysis of accelerated degradation tests for the stability of biological standards. I. Properties of maximum likelihood estimators. J. Biol. Stand. 12: 195-206.
7. Sokhey, J., Gupta, C. K., Sharma, B. and Singh, H. 1988. Stability of oral polio vaccine at different temperatures. Vaccine 6: 12-13.
8. Pipkin, P. A. and Minor, P. D. 1998. Studies on the loss of infectivity of live type 3 polio-vaccine on storage. Biologicals 26: 17-23.
9. Mirchamsy, H., Shafyi, A., Mahinpour, M. and Nazari, P. 1978. Stabilizing effect of magnesium chloride and sucrose on Sabin live polio vaccine. Dev. Biol. Stand. 41: 255-257.
10. Mauler, R. and Gruschkau, H. 1978. On stability of oral polio virus vaccines. Dev. Biol. Stand. 41: 267.
11. Zaffran, M. 1996. Vaccine transport and storage: Environmental challenges. Dev. Biol. Stand. 87: 9-17.
12. Wang, D. Y., Yang, R. I., Yang, Y. C., Yeh, S. Y., Chen, T. L., Cheng, H. F., Hsing, J. T. and Lin, C. P. 1999. The relationship between the cold chain system and vaccine potency in Taiwan: (I) Live measles vaccine and MMR vaccine. J. Food Drug Anal. 7: 233-242.
13. World Health Organization. 1995. Manual of laboratory methods for testing the potency of final vaccines used in the WHO Expended Progra-mme on Immunization. WHO/BLG/ 95.1.
14. Arya, S. C. 1998. Laboratory tests for live attenuated poliovirus vaccine. Biologicals 26: 245-246.
15. Yang, R. I., Chen, T. L., Jan, D. R., Hsieh, J. T., Lin, C. P. and Suen, T. T. 1995. The evaluation of the relationship between cold chain system and oral polio vaccine potency. Ann. Sci. Rep. Natl. Lab. Foods Drugs 13: 187.
16. Reed, L. J. and Muench, H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hygiene 27: 493-497.
17. Melnick, J. L. 1996. Thermostability of poliovirus and measles vaccines. Dev. Biol. Stand. 87: 155-160.
18. 2O). Vaccine 13: 1058-1063.
19. Rombaut, B., Andries, K. and Boeye, A. 1996. Stabilization of poliovirus with pirodavir. Dev. Biol. Stand. 87: 173-180.